Glucose 1,6-bisphosphate (Glc-1,6-P 2 ) concentration in brain is much higher than what is required for the functioning of phosphoglucomutase, suggesting that this compound has a role other than as a cofactor of phosphomutases. In cell-free systems, Glc-1,6-P 2 is formed from 1,3-bisphosphoglycerate and Glc-6-P by two related enzymes: PGM2L1 (phosphoglucomutase 2-like 1) and, to a lesser extent, PGM2 (phosphoglucomutase 2). It is hydrolyzed by the IMP-stimulated brain Glc-1,6-bisphosphatase of still unknown identity. Our aim was to test whether Glc-1,6-bisphosphatase corresponds to the phosphomannomutase PMM1, an enzyme of mysterious physiological function sharing several properties with Glc-1,6-bisphosphatase. We show that IMP, but not other nucleotides, stimulated by >100-fold (K a ≈ 20 M) the intrinsic Glc-1,6-bisphosphatase activity of recombinant PMM1 while inhibiting its phosphoglucomutase activity. No such effects were observed with PMM2, an enzyme paralogous to PMM1 that physiologically acts as a phosphomannomutase in mammals. Transfection of HEK293T cells with PGM2L1, but not the related enzyme PGM2, caused an ≈20-fold increase in the concentration of Glc-1,6-P 2 . Transfection with PMM1 caused a profound decrease (>5-fold) in Glc-1,6-P 2 in cells that were or were not cotransfected with PGM2L1. Furthermore, the concentration of Glc-1,6-P 2 in wildtype mouse brain decreased with time after ischemia, whereas it did not change in PMM1-deficient mouse brain. Taken together, these data show that PMM1 corresponds to the IMP-stimulated Glc-1,6-bisphosphatase and that this enzyme is responsible for the degradation of Glc-1,6-P 2 in brain. In addition, the role of PGM2L1 as the enzyme responsible for the synthesis of the elevated concentrations of Glc-1,6-P 2 in brain is established.Glucose 1,6-bisphosphate (Glc-1,6-P 2 ), 2 a well known cofactor for phosphoglucomutase and other sugar phosphomutases (1), is ubiquitously present in tissues. Its concentration is particularly elevated in brain, where it reaches values of Ͼ100 M (2), i.e. Ͼ1000-fold higher than the concentrations required to stimulate phosphoglucomutase. Glc-1,6-P 2 has been proposed to be an effector for several enzymes. Phosphofructokinase (3, 4) and liver pyruvate kinase (5) are both stimulated by this compound, whereas low K m hexokinases (6 -8), 6-phosphogluconate dehydrogenase (9), and fructose-1,6-bisphosphatase (10) are inhibited. These effects have been demonstrated in vitro, but under conditions that are not necessarily physiologically relevant. In addition, the occurrence of this regulation in intact cells has not been demonstrated.Glc-1,6-P 2 is synthesized from 1,3-bisphosphoglycerate and glucose 1-phosphate or glucose 6-phosphate by Glc-1,6-P 2 synthase, an enzyme particularly abundant in brain (11) and recently identified as PGM2L1 (phosphoglucomutase 2-like 1) (12). In vitro, the related enzyme PGM2 (phosphoglucomutase 2), which shares ϳ60% identity with PGM2L1 and acts mainly as a phosphopentomutase, also catalyzes the synthesis of...